Heba Mitwalli

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Heba Mitwalli sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials none currently recruiting 1 completed later-stage tilt upper half by trial count

Heba Mitwalli: 1 sponsored US clinical trial, none currently recruiting.

Heba Mitwalli sponsors 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 1 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Caries, with 1 trials.

Mid-pack sponsor footprint

Heba Mitwalli is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Phase Distribution

PhaseTrial count
Phase 4 1

Therapeutic Areas

Caries 1

How the Heba Mitwalli archive is shaped

1 indexed studies, none listed as recruiting (0% open); 1 completed (100%).

Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Caries (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Heba Mitwalli: archived-pipeline peers nationwide

Peers matched on 1 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Heba Mitwalli sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60% Total trials Recruiting share Heba Mitwalli1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO Health10xBio22nd Century Group23andMe3-C Institute for Social Development
Heba Mitwalli sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Heba Mitwalli sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Heba Mitwalli page

1 registered trials is a research-attention snapshot, not an endorsement of Heba Mitwalli or any single study.

  • None of Heba Mitwalli's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Caries is the condition Heba Mitwalli studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Caries trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Heba Mitwalli pipeline card: 1 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.